View in EDS

The case for tumour-agnostic reimbursement of dual immunotherapy.

Saved in:
Bibliographic Details
Title: The case for tumour-agnostic reimbursement of dual immunotherapy.
Authors: Subbiah, Vivek1 (AUTHOR) viveksubbiah@outlook.com, Kurzrock, Razelle2,3 (AUTHOR)
Source: European Journal of Cancer. Jun2026, Vol. 241, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2026.116784